Check out how Exploristics can help get clinical trials back on track after disruption due to COVID-19
Unexpected disruption to clinical trials, such as that seen in the global COVID-19 pandemic, can have a devastating impact on patients and healthcare systems and cause numerous unforeseen challenges for developers of medicines, medical diagnostics and devices. At Exploristics, they offer a unique package of statistical expertise and tools to address issues arising from the current situation, helping healthcare and life sciences organisations overcome the challenge and getting trials back on track.
Something new is coming from GIANT..
We’re excited to announce the official launch of GIANT Thinking, a new podcast that tells the stories about world-class experts from #healthcare, #Industry and #technology.
Stay tuned on our social media channels in the…
Monday 17th August 2020, 2:00pm (London UK - BST) 45mins
What will the talk cover?
The current pace and scale of health care innovation has led to the emergence of a broad range of new digital health technologies which…